{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:41:18Z","timestamp":1788536478040,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1053\/j.seminhematol.2022.11.003","type":"journal-article","created":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T12:45:28Z","timestamp":1669725928000},"page":"177-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Hepatitis C virus-associated B-cell lymphomas: The importance of the new direct antiviral agent therapy"],"prefix":"10.1053","volume":"59","author":[{"given":"Cesare","family":"Mazzaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8746-9404","authenticated-orcid":false,"given":"Riccardo","family":"Bomben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Gragnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"Visentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Pozzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Pozzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Zucchetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valter","family":"Gattei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1053\/j.seminhematol.2022.11.003_bib0001","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.cmi.2016.07.035","article-title":"Hepatitis C: global epidemiology and strategies for control","volume":"22","author":"Lanini","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"21","key":"10.1053\/j.seminhematol.2022.11.003_bib0002","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1056\/NEJM199211193272104","article-title":"A role for hepatitis C virus infection in type II cryoglobulinemia","volume":"327","author":"Agnello","year":"1992","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"10.1053\/j.seminhematol.2022.11.003_bib0003","first-page":"SII20","article-title":"HCV and cryoglobulinemic vasculitis","volume":"69","author":"Ferri","year":"2002","journal-title":"Cleve Clin J Med"},{"issue":"11","key":"10.1053\/j.seminhematol.2022.11.003_bib0004","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJMra2033539","article-title":"Extrahepatic manifestations of chronic HCV infection","volume":"384","author":"Cacoub","year":"2021","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1053\/j.seminhematol.2022.11.003_bib0005","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1158\/1055-9965.EPI-06-0308","article-title":"Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies","volume":"15","author":"Dal Maso","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1053\/j.seminhematol.2022.11.003_bib0006","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jhep.2021.09.023","article-title":"HCV-related lymphoproliferative disorders in the direct-acting antiviral era: from mixed cryoglobulinaemia to B-cell lymphoma","volume":"76","author":"Cacoub","year":"2022","journal-title":"J Hepatol"},{"issue":"5390","key":"10.1053\/j.seminhematol.2022.11.003_bib0007","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","article-title":"Binding of hepatitis C virus to CD81","volume":"282","author":"Pileri","year":"1998","journal-title":"Science"},{"issue":"1","key":"10.1053\/j.seminhematol.2022.11.003_bib0008","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41572-018-0009-4","article-title":"Cryoglobulinaemia","volume":"4","author":"Roccatello","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1053\/j.seminhematol.2022.11.003_bib0009","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/archinte.165.1.101","article-title":"Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias","volume":"165","author":"Monti","year":"2005","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1053\/j.seminhematol.2022.11.003_bib0010","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1136\/gutjnl-2017-313983","article-title":"The effect of sustained virological response on the risk of extrahepatic manifestations of hepatitis C virus infection","volume":"67","author":"Mahale","year":"2018","journal-title":"Gut"},{"issue":"2","key":"10.1053\/j.seminhematol.2022.11.003_bib0011","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMoa013376","article-title":"Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection","volume":"347","author":"Hermine","year":"2002","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1053\/j.seminhematol.2022.11.003_bib0012","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1200\/JCO.2005.06.008","article-title":"Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience","volume":"23","author":"Vallisa","year":"2005","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1053\/j.seminhematol.2022.11.003_bib0013","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2141.2008.07565.x","article-title":"Pegylated-interferon plus ribavirin for HCV-positive indolent non-Hodgkin lymphomas","volume":"145","author":"Mazzaro","year":"2009","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1053\/j.seminhematol.2022.11.003_bib0014","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1111\/liv.12897","article-title":"HCV-associated B-cell non-Hodgkin lymphomas and new direct antiviral agents","volume":"35","author":"Carrier","year":"2015","journal-title":"Liver Int"},{"issue":"21","key":"10.1053\/j.seminhematol.2022.11.003_bib0015","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1182\/blood-2016-05-714667","article-title":"Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection","volume":"128","author":"Arcaini","year":"2016","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.seminhematol.2022.11.003_bib0016","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1038\/s41375-019-0687-2","article-title":"Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection","volume":"34","author":"Frigeni","year":"2020","journal-title":"Leukemia"},{"issue":"8","key":"10.1053\/j.seminhematol.2022.11.003_bib0017","doi-asserted-by":"crossref","first-page":"e720","DOI":"10.1634\/theoncologist.2018-0331","article-title":"Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas","volume":"24","author":"Merli","year":"2019","journal-title":"Oncologist"},{"issue":"1","key":"10.1053\/j.seminhematol.2022.11.003_bib0018","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep.29364","article-title":"Efficacy and safety of new direct antiviral agents in hepatitis C virus-infected patients with diffuse large B-cell non-Hodgkin's lymphoma","volume":"67","author":"Persico","year":"2018","journal-title":"Hepatology"},{"issue":"10","key":"10.1053\/j.seminhematol.2022.11.003_bib0019","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/0959-8049(94)90066-3","article-title":"Hepatitis C virus infection and B-cell lymphomas","volume":"30A","author":"Ferri","year":"1994","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1053\/j.seminhematol.2022.11.003_bib0020","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1053\/j.gastro.2003.09.025","article-title":"Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis","volume":"125","author":"Gisbert","year":"2003","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1053\/j.seminhematol.2022.11.003_bib0021","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cgh.2008.02.011","article-title":"Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium","volume":"6","author":"de Sanjose","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1053\/j.seminhematol.2022.11.003_bib0022","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/annonc\/mdp454","article-title":"Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT","volume":"21","author":"Paulli","year":"2010","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1053\/j.seminhematol.2022.11.003_bib0023","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1182\/blood-2004-05-1711","article-title":"Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity?","volume":"105","author":"Saadoun","year":"2005","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2022.11.003_bib0024","doi-asserted-by":"crossref","first-page":"294","DOI":"10.7326\/0003-4819-129-4-199808150-00005","article-title":"Prevalence of monoclonal gammopathies in patients with hepatitis C virus infection","volume":"129","author":"Andreone","year":"1998","journal-title":"Ann Intern Med"},{"issue":"18","key":"10.1053\/j.seminhematol.2022.11.003_bib0025","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1001\/jama.297.18.2010","article-title":"Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus","volume":"297","author":"Giordano","year":"2007","journal-title":"JAMA"},{"issue":"4","key":"10.1053\/j.seminhematol.2022.11.003_bib0026","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jhep.2015.04.021","article-title":"Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006-2010","volume":"63","author":"Allison","year":"2015","journal-title":"J Hepatol"},{"issue":"Suppl 2","key":"10.1053\/j.seminhematol.2022.11.003_bib0027","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3851\/IMP3250","article-title":"Expert opinion on managing chronic HCV in patients with non-Hodgkin lymphoma and other extrahepatic malignancies","volume":"23","author":"Ferri","year":"2018","journal-title":"Antivir Ther"},{"issue":"2","key":"10.1053\/j.seminhematol.2022.11.003_bib0028","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1182\/blood.V90.2.776.776_776_782","article-title":"Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection","volume":"90","author":"De Vita","year":"1997","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.seminhematol.2022.11.003_bib0029","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ijc.31110","article-title":"Clinicopathologic characteristics and outcomes of transformed diffuse large B-cell lymphoma in hepatitis C virus-infected patients","volume":"142","author":"Hosry","year":"2018","journal-title":"Int J Cancer"},{"issue":"12","key":"10.1053\/j.seminhematol.2022.11.003_bib0030","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1073\/pnas.0303971101","article-title":"Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes","volume":"101","author":"Machida","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1053\/j.seminhematol.2022.11.003_bib0031","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1177\/2040620715623924","article-title":"Hepatitis C virus-associated B-cell non-Hodgkin's lymphomas: what do we know?","volume":"7","author":"Vannata","year":"2016","journal-title":"Ther Adv Hematol"},{"issue":"2","key":"10.1053\/j.seminhematol.2022.11.003_bib0032","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41435-020-0093-9","article-title":"A stereotyped light chain may shape virus-specific B-cell receptors in HCV-dependent lymphoproliferative disorders","volume":"21","author":"Minafo","year":"2020","journal-title":"Genes Immun"},{"issue":"6","key":"10.1053\/j.seminhematol.2022.11.003_bib0033","doi-asserted-by":"crossref","first-page":"E210","DOI":"10.1002\/ajh.26167","article-title":"Mutational and immunogenetic landscape of HCV-associated B-cell lymphoproliferative disorders","volume":"96","author":"Defrancesco","year":"2021","journal-title":"Am J Hematol"},{"issue":"7","key":"10.1053\/j.seminhematol.2022.11.003_bib0034","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1080\/1042819031000076972","article-title":"Hepatitis C virus (HCV) and lymphomagenesis","volume":"44","author":"Weng","year":"2003","journal-title":"Leuk Lymphoma"},{"issue":"13","key":"10.1053\/j.seminhematol.2022.11.003_bib0035","doi-asserted-by":"crossref","first-page":"8079","DOI":"10.1128\/JVI.79.13.8079-8089.2005","article-title":"Hepatitis C virus E2-CD81 interaction induces hypermutation of the immunoglobulin gene in B cells","volume":"79","author":"Machida","year":"2005","journal-title":"J Virol"},{"issue":"2","key":"10.1053\/j.seminhematol.2022.11.003_bib0036","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jhep.2008.03.031","article-title":"Association of t(14;18) translocation with HCV infection in gastrointestinal MALT lymphomas","volume":"49","author":"Libra","year":"2008","journal-title":"J Hepatol"},{"issue":"7","key":"10.1053\/j.seminhematol.2022.11.003_bib0037","doi-asserted-by":"crossref","first-page":"571","DOI":"10.7326\/0003-4819-137-7-200210010-00008","article-title":"Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas","volume":"137","author":"Zignego","year":"2002","journal-title":"Ann Intern Med"},{"issue":"15","key":"10.1053\/j.seminhematol.2022.11.003_bib0038","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1158\/1078-0432.CCR-06-0154","article-title":"Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma","volume":"12","author":"Feldmann","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1053\/j.seminhematol.2022.11.003_bib0039","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/rheumatology\/kel177","article-title":"Hepatitis C virus-associated B-cell proliferation\u2013the role of serum B lymphocyte stimulator (BLyS\/BAFF)","volume":"46","author":"Sene","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1053\/j.seminhematol.2022.11.003_bib0040","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/hon.3008","article-title":"B-cell activating factor (BAFF), BAFF promoter and BAFF receptor allelic variants in hepatitis C virus related Cryoglobulinemic Vasculitis and Non-Hodgkin's Lymphoma","volume":"40","author":"Gragnani","year":"2022","journal-title":"Hematol Oncol"},{"issue":"16","key":"10.1053\/j.seminhematol.2022.11.003_bib0041","doi-asserted-by":"crossref","first-page":"8835","DOI":"10.1128\/JVI.78.16.8835-8843.2004","article-title":"Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes","volume":"78","author":"Machida","year":"2004","journal-title":"J Virol"},{"issue":"2","key":"10.1053\/j.seminhematol.2022.11.003_bib0042","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3324\/haematol.2014.116855","article-title":"The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection","volume":"100","author":"Arcaini","year":"2015","journal-title":"Haematologica"},{"issue":"42","key":"10.1053\/j.seminhematol.2022.11.003_bib0043","doi-asserted-by":"crossref","first-page":"71528","DOI":"10.18632\/oncotarget.17655","article-title":"Notch4 and mhc class II polymorphisms are associated with hcv-related benign and malignant lymphoproliferative diseases","volume":"8","author":"Gragnani","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1053\/j.seminhematol.2022.11.003_bib0044","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/cells10010016","article-title":"Role of notch receptors in hematologic malignancies","volume":"10","author":"Gragnani","year":"2020","journal-title":"Cells"},{"issue":"7","key":"10.1053\/j.seminhematol.2022.11.003_bib0045","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/gene.2014.41","article-title":"Genome-wide association study of hepatitis C virus- and cryoglobulin-related vasculitis","volume":"15","author":"Zignego","year":"2014","journal-title":"Genes Immun"},{"issue":"8","key":"10.1053\/j.seminhematol.2022.11.003_bib0046","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/hep4.1389","article-title":"Eradication of Hepatitis C Virus Is Associated With Reduction in Hematologic Malignancies: Major Differences Between Interferon and Direct-Acting Antivirals","volume":"3","author":"Ioannou","year":"2019","journal-title":"Hepatol Commun"},{"issue":"11","key":"10.1053\/j.seminhematol.2022.11.003_bib0047","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1111\/apt.15240","article-title":"The effects of sustained virological response to direct-acting anti-viral therapy on the risk of extrahepatic manifestations of hepatitis C infection","volume":"49","author":"El-Serag","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"38","key":"10.1053\/j.seminhematol.2022.11.003_bib0048","doi-asserted-by":"crossref","first-page":"8447","DOI":"10.3748\/wjg.v22.i38.8447","article-title":"Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma","volume":"22","author":"Merli","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1053\/j.seminhematol.2022.11.003_bib0049","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/annonc\/mdu166","article-title":"Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi","volume":"25","author":"Arcaini","year":"2014","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1053\/j.seminhematol.2022.11.003_bib0050","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.autrev.2017.03.004","article-title":"International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement","volume":"16","author":"Zignego","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1053\/j.seminhematol.2022.11.003_bib0051","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jhep.2015.03.025","article-title":"EASL Recommendations on Treatment of Hepatitis C 2015","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"10.1053\/j.seminhematol.2022.11.003_bib0052","doi-asserted-by":"crossref","DOI":"10.1002\/hon.2862","article-title":"Hepatitis C virus-associated indolent B-cell lymphomas: A review on the role of the new direct antiviral agents therapy","author":"Mazzaro","year":"2021","journal-title":"Hematol Oncol"},{"issue":"10","key":"10.1053\/j.seminhematol.2022.11.003_bib0053","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162965","article-title":"Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study","volume":"11","author":"Alric","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1053\/j.seminhematol.2022.11.003_bib0054","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3851\/IMP3322","article-title":"miRNA-26b downregulation in peripheral blood mononuclear cells of patients with hepatitis C associated lymphomas is restored by successful interferon-free antiviral therapy","volume":"24","author":"Peveling-Oberhag","year":"2019","journal-title":"Antivir Ther"},{"issue":"2","key":"10.1053\/j.seminhematol.2022.11.003_bib0055","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"Electronic address eee, European Association for the Study of the L. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J Hepatol"},{"issue":"9","key":"10.1053\/j.seminhematol.2022.11.003_bib0056","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.6004\/jnccn.2014.0125","article-title":"Non-Hodgkin's lymphomas, version 4.2014","volume":"12","author":"Zelenetz","year":"2014","journal-title":"J Natl Compr Canc Netw"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196322000592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196322000592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:28:16Z","timestamp":1758522496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196322000592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0037196322000592"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2022.11.003","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C virus-associated B-cell lymphomas: The importance of the new direct antiviral agent therapy","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2022.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}